Sofidel Tissue Expansion: A Major Move Reshaping Its U.S. Footprint

Sofidel tissue expansion marks a major step in the company’s North American strategy, as Italian tissue producer Sofidel finalizes a $775 million investment to expand its integrated tissue production hub in Inola, Oklahoma, creating a significant Signature Sheet moment for the company.

The project strengthens Sofidel’s position in the evolving Paper Chain of global tissue production, where companies are building larger and more efficient production ecosystems.

The expansion will add a Through-Air-Drying (TAD) tissue machine, additional converting lines, and advanced logistics infrastructure. These upgrades position the Inola facility as a Paper Core production hub designed for scale, automation, and growing premium tissue demand.

The Numbers Behind Sofidel’s Big U.S. Bet

The scale of the project highlights its strategic importance:

• $775 million total investment
• 75,000 tonnes annual production capacity
• Nearly 1 million sq. ft. of new facilities
• 100,000 pallet positions in an automated warehouse
• Production expected to start in Q2 2028

Industry observers see investments like this as Paper Index signals of rising tissue demand, creating a stronger Paper Pulse across the North American tissue market.

Read Also: A Packaging Reset Is Coming-Amcor Just Moved First.

Inside the Production System Powering Sofidel’s Expansion

The Inola expansion is designed as a fully integrated Paper Engine for tissue production.

Key components include:

Premium Tissue Production
A new TAD machine producing higher-quality tissue products.

Converting Operations
Additional converting lines transforming parent reels into finished consumer products.

Automated Logistics
Automated warehouses and internal transport systems improving efficiency and material flow.

Together these elements create a Paper Grid of production, converting, and logistics, supporting a broader Circular Metabolism approach to resource efficiency.

The Strategic Move Positioning Sofidel for the Next Demand Wave

Sofidel’s investment aims to:

• strengthen its presence in the U.S. tissue market
• expand premium tissue production
• improve operational efficiency through automation
• support the fast-growing private label tissue segment

These upgrades align with the company’s broader Green Ledger strategy, balancing production growth with sustainability goals.

A Bigger Signal from the Global Tissue Industry

The Inola expansion reflects a wider transformation in the tissue sector.

Producers are increasingly investing in large, automated production hubs that integrate fiber processing, paper production, converting, and logistics within one Paper Sphere of operations.

Projects like this represent another step in the industry’s Paper Rise toward large-scale, technology-driven tissue production.

Is the tissue industry entering the era of mega-scale production hubs?

Reference – Sofidel